{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:23:30Z","timestamp":1787261010094,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ctro.2026.101207","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:15:52Z","timestamp":1780445752000},"page":"101207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Is rectal preparation necessary in contemporary image-guided prostate radiotherapy?"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3916-5174","authenticated-orcid":false,"given":"S.E.","family":"Alexander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Delacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Garrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4351-8136","authenticated-orcid":false,"given":"S.","family":"Nill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ockwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Oelfke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7389-5587","authenticated-orcid":false,"given":"H.A.","family":"McNair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Tree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101207_b0005","unstructured":"European Cancer Information System. 2020 new cases (incidence) and deaths (mortality) estimates Prostate cancer burden in EU-27. 2021."},{"key":"10.1016\/j.ctro.2026.101207_b0010","unstructured":"National Prostate Cancer Audit, National Cancer Audit Collaborating Centre. National Prostate Cancer Audit State of the Nation Report 2025. 2025."},{"key":"10.1016\/j.ctro.2026.101207_b0015","unstructured":"European Commission. 2020 new cases (incidence) and deaths (mortality) estimates Prostate cancer burden in EU-27. 2023."},{"key":"10.1016\/j.ctro.2026.101207_b0020","unstructured":"Radiotherapy Board. On target 2: updated guidance for image-guided radiotherapy Radiotherapy Board 2021:182."},{"key":"10.1016\/j.ctro.2026.101207_b0025","doi-asserted-by":"crossref","unstructured":"Ghadjar P, Fiorino C, Munck af Rosensch\u00f6ld P, Pinkawa M, Zilli T, van der Heide UA. ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer. Radiotherapy and Oncology 2019;141:5\u201313. https:\/\/doi.org\/10.1016\/J.RADONC.2019.08.027.","DOI":"10.1016\/j.radonc.2019.08.027"},{"key":"10.1016\/j.ctro.2026.101207_b0030","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.semradonc.2025.04.007","article-title":"Advancing prostate cancer treatment: a review of CT and MR-guided online adaptive radiotherapy techniques","volume":"35","author":"Casillas","year":"2025","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0035","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2004.11.032","article-title":"Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy","volume":"62","author":"de Crevoisier","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101207_b0040","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijrobp.2008.08.007","article-title":"Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers","volume":"74","author":"Engels","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101207_b0045","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.ijrobp.2006.11.014","article-title":"Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the dutch trial of 68 GY versus 78 Gy","volume":"67","author":"Heemsbergen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101207_b0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.semradonc.2007.09.008","article-title":"Image-guided radiotherapy for localized prostate cancer: treating a moving target","volume":"18","author":"Kupelian","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000441225","article-title":"Degree of rectal distension seen on prostate radiotherapy planning CT Scan is not a negative prognostic factor in the modern era of image-guided radiotherapy","volume":"90","author":"Silverman","year":"2015","journal-title":"Oncology"},{"key":"10.1016\/j.ctro.2026.101207_b0060","article-title":"Prostate cancer image guided radiotherapy: why the commotion over rectal volume and motion?","volume":"43","author":"Alexander","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0065","unstructured":"Radiotherapy Quality Assurance Team RTQA. A phase III randomised trial of 5 fraction prostate SBRT versus 5 fraction prostate and pelvic nodal SBRT: Radiotherapy planning and delivery guidelines. 2023."},{"key":"10.1016\/j.ctro.2026.101207_b0070","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.1016\/S0167-8140(23)08843-6","article-title":"PD-0312 Audit of prostate cancer planning CT rescan rate and value","volume":"182","author":"Alexander","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0075","article-title":"Ultrahypofractionated radiotherapy for localised prostate cancer: the impact of daily MRI-guided adaptive radiotherapy on delivered dose","volume":"53","author":"Alexander","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.radonc.2021.12.037","article-title":"Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: a post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy","volume":"167","author":"Ma","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.radonc.2008.03.016","article-title":"Dosimetric evaluation of prostate rotations and their correction by couch rotations","volume":"88","author":"van Herten","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2022.02.002","article-title":"Seminal vesicle inter- and intra-fraction motion during radiotherapy for prostate cancer: a review","volume":"169","author":"Brand","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0095","doi-asserted-by":"crossref","unstructured":"de Muinck Keizer DM, Willigenburg T, van der Voort van Zyp JRN, Raaymakers BW, Lagendijk JJW, de Boer JCJ. Seminal vesicle intrafraction motion during the delivery of radiotherapy sessions on a 1.5 T MR-Linac. Radiotherapy and Oncology 2021;162:162\u2013169. https:\/\/doi.org\/10.1016\/j.radonc.2021.07.014.","DOI":"10.1016\/j.radonc.2021.07.014"},{"key":"10.1016\/j.ctro.2026.101207_b0100","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.meddos.2011.09.002","article-title":"Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer","volume":"37","author":"Stenmark","year":"2012","journal-title":"Med Dosim"},{"key":"10.1016\/j.ctro.2026.101207_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-9-174","article-title":"Seminal vesicle intrafraction motion analysed with cinematic magnetic resonance imaging","volume":"9","author":"Gill","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0110","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.3390\/curroncol30070483","article-title":"Seminal vesicle treatment for localized prostate cancer treated with external beam radiotherapy","volume":"30","author":"Steed","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0115","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.juro.2008.08.037","article-title":"The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from southwest oncology group 8794","volume":"180","author":"Swanson","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.ctro.2026.101207_b0120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.prro.2014.06.005","article-title":"A systematic review: Effectiveness of rectal emptying preparation in prostate cancer patients","volume":"4","author":"McNair","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0125","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-021-01916-0","article-title":"Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer","volume":"16","author":"Schaule","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-021-01872-9","article-title":"Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy","volume":"16","author":"Eckl","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/acm2.13399","article-title":"Prospects for daily online adaptive radiotherapy via ethos for prostate cancer patients without nodal involvement using unedited CBCT auto-segmentation","volume":"22","author":"Moazzezi","year":"2021","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ctro.2026.101207_b0140","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-025-02697-6","article-title":"AI-driven online adaptive radiotherapy in prostate cancer treatment: considerations on activity time and dosimetric benefits","volume":"20","author":"Preziosi","year":"2025","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0145","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.clon.2021.03.004","article-title":"Variations in demand across england for the magnetic resonance-linac technology, simulated utilising local-level demographic and cancer data in the malthus project","volume":"33","author":"Mee","year":"2021","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.semradonc.2023.10.015","article-title":"The future of MR-guided radiation therapy","volume":"34","author":"Guckenberger","year":"2024","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0155","article-title":"Geometric uncertainties in daily online IGRT: refining the CTV-PTV margin for contemporary photon radiotherapy","author":"Tudor","year":"2020","journal-title":"Br Inst Radiol"},{"key":"10.1016\/j.ctro.2026.101207_b0160","doi-asserted-by":"crossref","unstructured":"de Muinck Keizer DM, Kerkmeijer LGW, Willigenburg T, van Lier ALHMW, Hartogh MD den, van der Voort van Zyp JRN, et al. Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac. Radiother Oncol 2020;151:88\u201394. https:\/\/doi.org\/10.1016\/j.radonc.2020.06.044.","DOI":"10.1016\/j.radonc.2020.06.044"},{"key":"10.1016\/j.ctro.2026.101207_b0165","first-page":"549","article-title":"Intra-fraction motion of the prostate is a random walk","volume":"60","author":"Ballhausen","year":"2015","journal-title":"Phys MedBiol"},{"key":"10.1016\/j.ctro.2026.101207_b0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.zemedi.2019.12.004","article-title":"Evaluation of intrafraction prostate motion tracking using the Clarity Autoscan system for safety margin validation","volume":"30","author":"Richter","year":"2020","journal-title":"Z Med Phys"},{"key":"10.1016\/j.ctro.2026.101207_b0175","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ijrobp.2008.01.004","article-title":"Reduction of prostate motion by removal of gas in rectum during radiotherapy","volume":"72","author":"Ogino","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101207_b0180","unstructured":"National Institute for Health and Care Excellence. Sodium citrate medicinal forms. British National Formulary 2025."},{"key":"10.1016\/j.ctro.2026.101207_b0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.clon.2014.10.010","article-title":"HERO (Health Economics in Radiation Oncology): a pan-european project on radiotherapy resources and needs","volume":"27","author":"Lievens","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101207_b0190","unstructured":"NHS England. NHS clinical waste strategy. A Greener NHS 2023."}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:24:31Z","timestamp":1787257471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"alternative-id":["S2405630826001023"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101207","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is rectal preparation necessary in contemporary image-guided prostate radiotherapy?","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101207"}}